resveratrol has been researched along with thyroxine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsequell, G; Blasi, D; Bosch, L; Centeno, NB; Cotrina, EY; Pinto, M; Planas, A; Quintana, J; Valencia, G; Vilà, M | 1 |
| Davis, FB; Davis, PJ; Lin, HY; Shih, A | 1 |
| Damas, AM; Morais-de-Sá, E; Pereira, PJ; Saraiva, MJ | 1 |
| Davis, FB; Davis, PJ; Hammond, D; Hercbergs, A; Keating, T; Lin, HY; Shih, A; Sun, M; Tang, HY; Wu, YH | 1 |
| Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B | 1 |
| Chen, FH; Chu, CH; Ge, JF; Li, N; Qin, G; Qiu, GL; Wang, CY; Xu, YY; Zhang, Y | 1 |
| Bennett, JA; Changou, CA; Chen, YR; Chin, YT; Davis, PJ; Fu, E; Ho, Y; Incerpi, S; Li, WS; Lin, CY; Lin, HY; Liu, LF; Mousa, SA; Nana, AW; Pedersen, JZ; Shih, YJ; Whang-Peng, J | 1 |
| Chen, YR; Cheng, TM; Chin, YT; Davis, PJ; Hercbergs, A; Ho, Y; Incerpi, S; Li, WS; Liao, YM; Lin, HY; Liu, LF; Liu, YR; Nana, AW; Pedersen, J; Shih, YJ; Whang-Peng, J; Wu, SY; Yang, YS | 1 |
| Changou, CA; Chen, YR; Chin, YT; Chiu, HC; Crawford, DR; Davis, PJ; Ho, Y; Huang, TY; Lee, SY; Li, ZL; Lin, HY; Mousa, SA; Pan, YS; Shih, YJ; Su, KW; Su, PY; Wang, K; Whang-Peng, J; Wu, CY; Yang, YSH | 1 |
| Baldissarelli, J; Chitolina Schetinger, MR; de Souza Cardoso, J; Duarte Junior, HR; Farias Martins Filho, AO; Morsch, VM; Pereira Soares, MS; Reichert, KP; Ribeiro Coriolano, FH; Spanevello, RM; Stefanello, FM; Tavares, RG; Teixeira, FC | 1 |
10 other study(ies) available for resveratrol and thyroxine
| Article | Year |
|---|---|
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Topics: Diflunisal; Flufenamic Acid; Halogenation; Humans; Kinetics; Ligands; Models, Molecular; Prealbumin; Protein Multimerization; Protein Structure, Secondary; Structure-Activity Relationship | 2013 |
Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase.
Topics: 3T3 Cells; Animals; Cell Fractionation; Cell Line; Cell Nucleus; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nuclear Proteins; Oligonucleotides, Antisense; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-jun; Receptors, Thyroid Hormone; Resveratrol; Serine; Stilbenes; Thyroxine; Transfection; Triiodothyronine; Tumor Suppressor Protein p53 | 2001 |
The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors.
Topics: Amyloid; Antioxidants; Binding Sites; Binding, Competitive; Carrier Proteins; Crystallography, X-Ray; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Design; Electrons; Escherichia coli; Humans; Hydrogen Bonding; Kinetics; Ligands; Models, Chemical; Models, Molecular; Prealbumin; Protein Binding; Protein Conformation; Resveratrol; Stilbenes; Thyroxine | 2004 |
Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated.
Topics: Apoptosis; Brain Neoplasms; Cyclooxygenase 2; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Glioma; Humans; Integrin alphaVbeta3; Phosphorylation; Protein Kinase C; Resveratrol; Stilbenes; Thyroxine | 2008 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cetuximab; Colonic Neoplasms; Computational Biology; Drug Therapy, Combination; Female; Humans; Models, Biological; Monte Carlo Method; Nanoparticles; Resveratrol; Stilbenes; Thyroxine | 2011 |
Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization.
Topics: Animals; Antioxidants; Asymptomatic Diseases; Behavior, Animal; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Hormone Replacement Therapy; Hypothyroidism; Learning Disabilities; Male; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neurons; Nootropic Agents; Random Allocation; Rats, Sprague-Dawley; Resveratrol; Spatial Learning; Stilbenes; Synaptotagmin I; Thyroxine | 2015 |
Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; HMGA2 Protein; Humans; Mice, Nude; Resveratrol; Thyroxine | 2018 |
Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Humans; Mice; Mice, Nude; Polyglactin 910; Resveratrol; Thyroxine; Xenograft Model Antitumor Assays | 2018 |
NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Topics: B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Drug Synergism; Gene Expression; Humans; Mouth Neoplasms; Polyglactin 910; Resveratrol; STAT3 Transcription Factor; Thyroxine | 2020 |
Neuroprotection elicited by resveratrol in a rat model of hypothyroidism: Possible involvement of cholinergic signaling and redox status.
Topics: Acetylcholinesterase; Animals; Antigens, Nuclear; Cholinergic Agents; Disease Models, Animal; Glial Fibrillary Acidic Protein; Hippocampus; Hypothyroidism; Male; Nerve Tissue Proteins; Neuroprotection; Oxidation-Reduction; Oxidative Stress; Rats, Wistar; Receptors, Cholinergic; Resveratrol; Signal Transduction; Thyroxine; Triiodothyronine | 2021 |